MacRaild Christopher A, Seow Jeffrey, Das Sreedam C, Norton Raymond S
Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade Parkville 3052 Australia.
Pept Sci (Hoboken). 2018 May;110(3):e24067. doi: 10.1002/pep2.24067. Epub 2018 Apr 14.
The development of clinically useful peptide-based vaccines remains a long-standing goal. This review highlights that intrinsically disordered protein antigens, which lack an ordered three-dimensional structure, represent excellent starting points for the development of such vaccines. Disordered proteins represent an important class of antigen in a wide range of human pathogens, and, contrary to widespread belief, they are frequently targets of protective antibody responses. Importantly, disordered epitopes appear invariably to be linear epitopes, rendering them ideally suited to incorporation into a peptide vaccine. Nonetheless, the conformational properties of disordered antigens, and hence their recognition by antibodies, frequently depend on the interactions they make and the context in which they are presented to the immune system. These effects must be considered in the design of an effective vaccine. Here we discuss these issues and propose design principles that may facilitate the development of peptide vaccines targeting disordered antigens.
开发临床上有用的基于肽的疫苗仍然是一个长期目标。本综述强调,缺乏有序三维结构的内在无序蛋白抗原是开发此类疫苗的理想起点。无序蛋白是多种人类病原体中的一类重要抗原,与普遍看法相反,它们经常是保护性抗体反应的靶点。重要的是,无序表位似乎总是线性表位,这使其非常适合纳入肽疫苗。尽管如此,无序抗原的构象特性,以及因此它们被抗体识别的情况,通常取决于它们所形成的相互作用以及它们呈递给免疫系统的背景。在设计有效的疫苗时必须考虑这些影响。在这里,我们讨论这些问题并提出可能有助于开发针对无序抗原的肽疫苗的设计原则。